SA
MRNA icon

Sanctuary Advisors’s Moderna MRNA Stock Holding History

Sanctuary Advisors’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.05M Buy
15,018
+1,897
+14% +$98.1K ﹤0.01% 1418
2026
Q1 		$667K Sell
13,121
-967
-7% -$45.1K ﹤0.01% 1581
2025
Q4 		$415K Buy
14,088
+2,529
+22% +$68.7K ﹤0.01% 1833
2025
Q3 		$299K Sell
11,559
-2,716
-19% -$75.8K ﹤0.01% 2006
2025
Q2 		$394K Buy
14,275
+644
+5% +$17K ﹤0.01% 1758
2025
Q1 		$386K Sell
13,631
-7,356
-35% -$261K ﹤0.01% 1649
2024
Q4 		$861K Buy
20,987
+2,656
+14% +$127K 0.01% 1344
2024
Q3 		$754K Sell
18,331
-10,747
-37% -$987K ﹤0.01% 1434
2024
Q2 		$3.14M Buy
+29,078
New +$3.68M 0.02% 624

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

Sanctuary Advisors's MRNA Position: Q2 2026 in Review

Sanctuary Advisors increased its Moderna (MRNA) stake by 14% in Q2 2026, buying an estimated $98.1K and bringing the position to 15,018 shares worth $1.05M. The position accounts for ﹤0.01% of the portfolio, ranked #1418.

Sanctuary Advisors first reported a position in MRNA in Q2 2024 and has held it in 9 quarters since. The position peaked at $3.14M in Q2 2024. 780 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • Sanctuary Advisors held 15,018 shares of Moderna worth $1.05M as of Q2 2026.
  • Sanctuary Advisors bought 1,897 Moderna shares in Q2 2026, an estimated $98.1K.
  • Moderna made up ﹤0.01% of Sanctuary Advisors's portfolio in Q2 2026, its #1418 holding.
  • Sanctuary Advisors first reported a position in Moderna in Q2 2024 and has held it in 9 quarters since.
  • Sanctuary Advisors's Moderna position peaked at $3.14M in Q2 2024.
  • 780 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Sanctuary Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.